BAY 80-6946

DRUG2 trials

Sponsors

University Hospital Of Ulm AöR, Universitaetsklinikum Muenster AöR

Conditions

Diffuse large B-cell lymphoma (DLBCL)Marginal Zone Lymphoma

Phase 2

Copanlisib and Rituximab in Marginal Zone Lymphoma Patients - A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY (COUP-1)

Active, not recruitingCTIS2022-500674-34-00

University Hospital Of Ulm AöRMarginal Zone Lymphoma

Start: 2019-11-04Target: 36Updated: 2025-04-30

A prospective multicenter phase 2 study of copanlisib in combination with rituximab and CHOP chemotherapy (COPA-R-CHOP) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL)

CompletedCTIS2024-517166-42-00

Universitaetsklinikum Muenster AöRDiffuse large B-cell lymphoma (DLBCL)

Start: 2020-05-29End: 2025-05-03Target: 61Updated: 2025-02-12